Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126105553 | 12610555 | 3 | F | 20160513 | 20160817 | 20160801 | 20160824 | EXP | RO-NMA-2016-SP11684 | RO-PFIZER INC-2016363954 | PFIZER | 38.00 | YR | F | Y | 0.00000 | 20160824 | MD | RO | RO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126105553 | 12610555 | 1 | PS | VANCOMYCIN HCL | VANCOMYCIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 2 G, DAILY | 301/15 | 62911 | 2 | G | |||||||
| 126105553 | 12610555 | 2 | SS | VANCOMYCIN HCL | VANCOMYCIN HYDROCHLORIDE | 1 | 62911 | ||||||||||||
| 126105553 | 12610555 | 3 | C | DIUREX | AMILORIDE HYDROCHLORIDEHYDROCHLOROTHIAZIDE | 1 | Oral | [FUROSEMIDE 20 MG]/[SPIRONOLACTONE 50 MG], 1X/DAY | 0 | QD | |||||||||
| 126105553 | 12610555 | 4 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 20 MG X 6 AMPOULES, 1X/DAY | 0 | QD | |||||||||
| 126105553 | 12610555 | 5 | C | SILDENAFIL. | SILDENAFIL | 1 | Oral | 20 MG, 3X/DAY | 6180 | MG | 0 | 20 | MG | TID | |||||
| 126105553 | 12610555 | 6 | C | MILURIT | ALLOPURINOL | 1 | Oral | 300 MG, 1X/DAY | 17700 | MG | 0 | 300 | MG | QD | |||||
| 126105553 | 12610555 | 7 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 20 MG, 1X/DAY | 1180 | MG | 0 | 20 | MG | QD | |||||
| 126105553 | 12610555 | 8 | C | SILIMARINA | 2 | Oral | 150 MG, 1X/DAY | 15450 | MG | 0 | 150 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126105553 | 12610555 | 1 | Medical device site infection |
| 126105553 | 12610555 | 2 | Staphylococcal infection |
| 126105553 | 12610555 | 3 | Cardiac failure congestive |
| 126105553 | 12610555 | 4 | Cardiac failure congestive |
| 126105553 | 12610555 | 5 | Pulmonary hypertension |
| 126105553 | 12610555 | 6 | Hyperuricaemia |
| 126105553 | 12610555 | 7 | Gastritis prophylaxis |
| 126105553 | 12610555 | 8 | Antiviral prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126105553 | 12610555 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126105553 | 12610555 | Eosinophilia | |
| 126105553 | 12610555 | Leukopenia | |
| 126105553 | 12610555 | Pruritus | |
| 126105553 | 12610555 | Pyrexia | |
| 126105553 | 12610555 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126105553 | 12610555 | 1 | 20160428 | 20160516 | 0 | |
| 126105553 | 12610555 | 3 | 20160316 | 20160517 | 0 | |
| 126105553 | 12610555 | 4 | 20160425 | 20160517 | 0 | |
| 126105553 | 12610555 | 5 | 20160201 | 20160517 | 0 | |
| 126105553 | 12610555 | 6 | 20160316 | 20160517 | 0 | |
| 126105553 | 12610555 | 7 | 20160316 | 20160517 | 0 | |
| 126105553 | 12610555 | 8 | 20160201 | 20160517 | 0 |